News
Media
Conferences
Partners
Publications
Events
CME/CE
Resources
PBM Directory
Subscribe

Spotlight -

AMCP Nexus 2025|

2025 Fall Clinical Dermatology|

Between the Lines: Diving Deeper Into the EMERALD Trial

Craig Coleman

Articles by Craig Coleman

FDA prioritizes drug safety, expects industry to be proactive

ByCraig Coleman

December 1st 2009

More than 4 million annual provider visits, including visits to the ER, can be attributed to adverse drug events

Latest Updated Articles

FDA prioritizes drug safety, expects industry to be proactive
Published: December 1st 2009 | Updated:

Trending on Managed Healthcare Executive

MHE Week in Review – HPV Vaccine Still Effective, Dry Eye Disease Lacks Effective Treatments and More

In America, Aging With HIV is a Continuous Challenge

Beyond the Primary End Point: Diving Deeper into the EMERALD trial | Written Recap

© 2025 MJH Life Sciences^®

All rights reserved.